Skip to main content

A bioactive fraction from Zingiber officinale and a process for the preparation thereof

Back to CFTRI Patents Database

Granted patent

Patent details

Patent number
296011
Date of patent
Country
India
IPC classification
A61K 36/00

Inventors

  • Shylaja M Dharmesh
  • Siddaraju M.N.

Abstract

Ulcer is a serious oxidative stress induced disease with complex pathologic events including upregulation of H+ K+ ATPase of parietal cell (PC) membrane, damage of mucin layer around PC, PC- DNA damage etc. The polysaccharide (GRPP) fraction and antioxidant extract (GRAOX) of ginger was examined for their ability to inhibit H+ K+ ATPase. Results indicated that the inhibition of H+ K+ ATPase activity which causes acidity in the lumen of the stomach, also exhibited better H+K+ATPase inhibition (PPI) at the IC50 of 27.2 µg (GRPP) and 16.5 µg GAE (AOX) respectively than the known antiulcer proton pump blocker Lansoprazole (19.3 µg). Further the antioxidant activity in antioxidant extract (GRAOX) by various assay systems was examined such as Reducing power, Free radical scavenging (FRS), DNA and cytoprotection systems etc. GRAOX exhibited concentration dependent reducing power ability at 5 - 25µg equivalent of phenol. FRS activity with IC50 of 6.8 µg equivalent of phenol etc. At 0.3µg level GRAOX offered > 80% protection to DNA and against FeSO4 - Ascorbate induced oxidation. The major active phenolic components were identified as Gallic acid / Tannic acid (46%), and Cinnamicacid (51%).

Accessibility options

Text size

Display
Yellow and white on black.
Light text on a dark background.
Show every link underlined.
More space between lines, words and letters.
Pause the slide show and moving lists.

Your choices are saved in this browser only.